Form4insider filings, from the source

SEC Form 4 · accession 0001645627-18-000044

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Aug 7, 2018
Accepted (ET)
Aug 16, 2018 · 11:08 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockAug 7, 2018P2,000$0.0279A25,409,498D
Common StockAug 7, 2018P3,000$0.03A25,412,498D
Common StockAug 7, 2018P2,000$0.03A25,414,498D
Common StockAug 7, 2018P2,000$0.0294A25,416,498D
Common StockAug 8, 2018P2,000$0.0288A25,418,498D
Common StockAug 8, 2018P1,000$0.029A25,419,498D
Common StockAug 8, 2018P2,000$0.0298A25,421,498D
Common StockAug 8, 2018P2,000$0.0296A25,423,498D
Common StockAug 8, 2018P2,000$0.0296A25,425,498D
Common StockAug 9, 2018P2,000$0.0298A25,427,498D
Common StockAug 9, 2018P2,000$0.03A25,429,498D
Common StockAug 9, 2018P3,000$0.0298A25,432,498D
Common StockAug 9, 2018P2,000$0.0298A25,434,498D
Common StockAug 9, 2018P500$0.03A25,434,998D
Common StockAug 10, 2018P2,000$0.0284A25,436,998D
Common StockAug 10, 2018P2,000$0.0284A25,438,998D
Common StockAug 10, 2018P2,000$0.0275A25,440,998D
Common StockAug 10, 2018P2,000$0.0275A25,442,998D
Common StockAug 10, 2018P2,000$0.0281A25,444,998D
Common StockAug 10, 2018P3,000$0.0281A25,447,998D
Common StockAug 10, 2018P3,000$0.0281A25,450,998D
Common StockAug 10, 2018P2,000$0.0282A25,452,998D
Common StockAug 10, 2018P3,000$0.0281A25,455,998D

Table II — derivative securities

No Table II lines on this filing.